Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.

PURPOSE Ephrin ligands and their Eph receptors are key regulators of endothelial cell (EC) proliferation, migration, adhesion, and repulsion during mammalian vascular development. The hypothesis was that these molecules also play a role in pathologic neovascularization (NV) in the mouse model of oxygen-induced retinopathy. METHODS C57BL/6 mice at postnatal day (P)7 were exposed to 75% oxygen (O(2)) for 5 days (until P12) and allowed to recover in room air to induce retinal NV. Retinas from unexposed and hyperoxia-exposed mice between P7 to P24 were analyzed specifically for EphrinB2 and EphB4 transcript expression by RT-PCR. Phospho-Eph (p-Eph) receptor was evaluated during active EC proliferation at P15 and P17 by immunohistology. Some hyperoxia-exposed mice had one eye injected intravitreally with 150 ng/1.5 microL of soluble EphrinB2/Fc or EphB4/Fc chimeras during transition from high O(2) to room air (P12) and injected again on P14. Contralateral eyes were injected with human IgG as the control. Preretinal nuclei and retinal blood vessels were quantified at peak disease (P17). RESULTS EphrinB2 mRNA was constitutively expressed in the developing retina and was unchanged by hyperoxia. In contrast, EphB4 mRNA expression was modulated during normal retinal development and was altered by hyperoxia. Furthermore, p-Eph was detected in developing preretinal tufts, thus implying that Ephrin/Eph signaling system is active in this experimental model. Intravitreal injection of soluble versions of these molecules significantly reduced pathologic neovascularization. The number of preretinal nuclei in hyperoxia-treated mice was reduced by 66% (P < 0.05) in EphrinB2-injected eyes, whereas EphB4 treatment yielded a 69% reduction (P < 0.05), compared with control injections. Intraretinal vessel development was not altered by the injections. CONCLUSIONS These results support the hypothesis that endogenous EphrinB2 and EphB4 are regulators of retinal NV during oxygen-induced retinopathy and may be useful targets for therapeutic intervention.

[1]  M. R. Powers,et al.  Increased retinal neovascularization in Fas ligand-deficient mice. , 2003, Investigative ophthalmology & visual science.

[2]  R. D'Amato,et al.  Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. , 1993, Microvascular research.

[3]  E. Pasquale,et al.  The Eph family of receptors. , 1997, Current opinion in cell biology.

[4]  H. Hayashi,et al.  Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases. , 2004, American journal of ophthalmology.

[5]  R. Klein,et al.  Eph receptors and ephrin ligands. essential mediators of vascular development. , 2000, Trends in cardiovascular medicine.

[6]  T. Suda,et al.  Distinct Roles of Ephrin-B2 Forward and EphB4 Reverse Signaling in Endothelial Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[7]  H. Augustin,et al.  Inhibition of tumor growth and angiogenesis by soluble EphB4. , 2004, Neoplasia.

[8]  G. Yancopoulos,et al.  Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. , 2001, Developmental biology.

[9]  Alan W. Stitt,et al.  Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina. , 2004, Molecular vision.

[10]  K. Murai,et al.  `Eph'ective signaling: forward, reverse and crosstalk , 2003, Journal of Cell Science.

[11]  X. Q. Zhang,et al.  Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells. , 2001, Blood.

[12]  Chad A. Cowan,et al.  Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. , 2004, Developmental biology.

[13]  D. O'Leary,et al.  Graded and lamina-specific distributions of ligands of EphB receptor tyrosine kinases in the developing retinotectal system. , 1997, Developmental biology.

[14]  J. Rosenbaum,et al.  Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. , 2003, Investigative ophthalmology & visual science.

[15]  P. Campochiaro,et al.  Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. , 2000, The American journal of pathology.

[16]  G. Yancopoulos,et al.  Eph family receptors and their ligands distribute in opposing gradients in the developing mouse retina. , 1996, Developmental biology.

[17]  Jin Chen,et al.  The ephrins and Eph receptors in angiogenesis. , 2002, Cytokine & growth factor reviews.

[18]  A. Pozzi,et al.  Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo , 2002, Oncogene.

[19]  Guoyao Wu,et al.  Role of ephrin B2 in human retinal endothelial cell proliferation and migration. , 2003, Cellular signalling.

[20]  Jürgen Löschinger,et al.  In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases , 1995, Cell.

[21]  S. Gerety,et al.  Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. , 2002, Development.

[22]  P. Campochiaro,et al.  Ocular neovascularization: a valuable model system , 2003, Oncogene.

[23]  E. Pasquale.  Eph–ephrin promiscuity is now crystal clear , 2004, Nature Neuroscience.

[24]  Alan W. Stitt,et al.  Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression. , 2003, Investigative ophthalmology & visual science.

[25]  H. Augustin,et al.  Inhibition of tumor growth and angiogenesis by soluble EphB4. , 2004, Neoplasia.

[26]  Chad A. Cowan,et al.  Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina. , 2000, Development.

[27]  V. Dixit,et al.  Reciprocal expression of the Eph receptor Cek5 and its ligand(s) in the early retina. , 1997, Developmental biology.

[28]  R. Adams.  Vascular patterning by Eph receptor tyrosine kinases and ephrins. , 2002, Seminars in cell & developmental biology.

[29]  T. Suda,et al.  Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells. , 2002, Blood.

[30]  Guoyao Wu,et al.  Eph B4 Receptor Signaling Mediates Endothelial Cell Migration and Proliferation via the Phosphatidylinositol 3-Kinase Pathway* , 2002, The Journal of Biological Chemistry.

[31]  J. Rosenbaum,et al.  Immunohistology of antigen-presenting cells in vivo: a novel method for serial observation of fluorescently labeled cells. , 2003, Investigative ophthalmology & visual science.

[32]  David J. Anderson,et al.  Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.

[33]  D. Anderson,et al.  Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. , 1999, Molecular cell.

[34]  A. Adamis,et al.  Ocular neovascularization: an epidemiologic review. , 1998, Survey of ophthalmology.

[35]  M. Greenberg,et al.  EphA Receptors Regulate Growth Cone Dynamics through the Novel Guanine Nucleotide Exchange Factor Ephexin , 2001, Cell.

[36]  A. Brändli,et al.  The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. , 2000, Development.

[37]  Gudrun Dandekar,et al.  Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells , 2003, Journal of Cell Science.

[38]  John G Flanagan,et al.  Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map , 1995, Cell.

[39]  D. Pode,et al.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. , 1999, The Journal of clinical investigation.

[40]  F. Diella,et al.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. , 1999, Genes & development.

[41]  C. Nobes,et al.  Rac-dependent trans-endocytosis of ephrinBs regulates Eph–ephrin contact repulsion , 2003, Nature Cell Biology.

[42]  G Garcia-Cardena,et al.  Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. , 2001, Developmental biology.

[43]  B. Tycko,et al.  Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation , 2002, Molecular Cancer.

[44]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[45]  G. Yancopoulos,et al.  EphB ligand, ephrinB2, suppresses the VEGF‐ and angiopoietin‐1‐induced Ras/mitogen‐activated protein kinase pathway in venous endothelial cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  D. Wilkinson,et al.  Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin‐B ligands , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[47]  Ming T. Lin,et al.  Expression of Tie-2, angiopoietin-1, angiopoietin-2, ephrinB2 and EphB4 in pyogenic granuloma of human gingiva implicates their roles in inflammatory angiogenesis. , 2000, Journal of periodontal research.

[48]  T. Pawson,et al.  Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands , 1996, Nature.

[49]  G. Yancopoulos,et al.  Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. , 2002, Molecular cancer research : MCR.

[50]  P. Campochiaro,et al.  Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.

[51]  M. Saint-Geniez,et al.  The msr/apj gene encoding the apelin receptor is an early and specific marker of the venous phenotype in the retinal vasculature. , 2003, Gene expression patterns : GEP.

[52]  K. Thierauch,et al.  EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration. , 2004, Biochemical and biophysical research communications.

[53]  F. Bonhoeffer,et al.  The Eph family in retinal axon guidance , 1997, Current Opinion in Neurobiology.

[54]  T. Suda,et al.  Ephrin-B2 Induces Migration of Endothelial Cells Through the Phosphatidylinositol-3 Kinase Pathway and Promotes Angiogenesis in Adult Vasculature , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[55]  P. Campochiaro,et al.  Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. , 1998, Investigative ophthalmology & visual science.